WILLOW ANNOUNCES NON-BROKERED PRIVATE PLACEMENT OFFERING TO RAISE UP TO $2.0 MILLION
Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on ...
Exclusive-Medicaid fuels US coverage of Novo, Lilly weight-loss drugs
U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...
Yahoo2 小时
Russians set alcohol purchase record in 2024: vodka tops the list
Source: RBC (Russian Business Consulting), a Russian news outlet, citing Rosalkogoltabakcontrol (the Russian federal service for alcohol market regulation) From January to October, 184.2 million ...
Medicaid fuels US coverage of Novo, Lilly weight-loss drugs
U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...
Eli Lilly and Novo want to shake off Ozempic copycats. Are they ready to meet demand?
The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...
studyfinds20 小时
8 health issues drugs like Wegovy may treat besides weight loss
Not only is Wegovy extremely effective (people lose about 15% of their body weight in a year), it also appears to have many ...
Doctors say RFK Jr.’s anti-Ozempic stance perpetuates stigma and misrepresents evidence
Robert F. Kennedy Jr. has pledged to tackle high rates of chronic diseases such as diabetes and obesity as President-elect ...